Octreotide Acetate for Injection
Indication
Hemostatic drugs. Mainly used for bleeding caused by excessive primary fibrinolysis, including acute and chronic, localized or systemic hyperfibrinolytic bleeding, the latter of which is common in cancer, leukemia, gynecological accidents, severe liver disease bleeding, etc.
Packaging Specification
0.1mg (in terms of octreotide)
Manufacturer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
-
Founded in:
2003-01-14 -
Address:
No. 699, Kejian Road, Jiangning Science Park, Nanjing -
Tax NO.:
91320100745398965U -
Registered Funds:
768 million yuan -
Website:
-
Email: